Here are relevant reports on : crispr-gene-editing-market
-
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029
The global gene editing market, valued at US$4.44 billion in 2023, stood at US$4.66 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.59 billion by the end of the period. The main factors driving the expansion of this market are the demand for personalized medicine and favorable government funding for gene editing projects.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029
The global gene transfer technologies market, valued at US$3.63 billion in 2023, stood at US$3.73 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$5.93 billion by the end of the period. The increasing usage in vaccine development and applications in cancer immunotherapy; is one of the major factors driving the growth of the gene transfer technologies market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Video Editing Market: Global Advancements, Business Models, Technology Roadmap, Worldwide Forecasts & Analysis (2013 – 2018)
As digital, high definition, file-based and multimedia ecosystems are replacing enterprise video segments, enterprises are focusing increasingly on video editing solutions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Reporter Gene Assay Market by Reagents & Assay kits (Luciferase, Green Fluorescent Protein, â-glucuronidase, â-galactosidase), Application (Gene Regulation, Protein Interaction, Cell Signalling Pathways), End Users, Region - Global Forecast to 2024
The reporter gene assay market is projected to reach USD 2.6 billion by 2024, at a CAGR of 10.1%. Factors contributing to the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and rising preference for cell-based assays. The prominent players in the reporter gene assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Danaher Corporation (US), Geno Technology (US), Genecopoeia, Inc. (US), InvivoGen (France), PromoCell (Germany), Becton, Dickinson and Company (US), Biotium, Inc. (US), Canvax (Spain), LI-COR, Inc. (US), System Biosciences, LLC (US), Indigo Biosciences, Inc. (US), BioThema (Sweden), Takara Bio Inc (US), BioAssay Systems (US), Cell Biolabs, Inc. (US), BPS Bioscience, Inc (US), Biosynth AG (Switzerland), and Cayman Chemical (US).
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)
The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Gene Prediction Tools Market - Global Forecast to 2030
Gene Prediction Tools Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Plant Breeding and CRISPR Plants Market by Type (Conventional Breeding and Biotechnological Method), Trait (Herbicide Tolerance, Disease Resistance, Yield & Grain Size Improvement, Temperature Tolerance), Technology, Application, and Region - Global Forecast to 2030
The global plant breeding and CRISPR plants market is projected to reach USD 13.86 billion by 2030, growing at a CAGR of 9.2% during the forecast period. The report profiles key players such as Bayer AG (Germany), KWS SAAT SE & Co. KGaA (Germany), Corteva (US), BASF (Germany), UPL (India), Rijk Zwaan Zaadteelt en Zaadhandel B.V. (Netherlands), Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA. (Switzerland), Sanatech Seed Co.,Ltd. (Japan), and Pairwise (US).
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Mice Model Market by Model Type (Inbred, Outbred, Hybrid), Service (Breeding, Rederivation), Application (Personalized Medicine), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology), End User (CROs) - Global Forecast to 2030
The global mice model market, valued at US$1.53 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 10.0% from 2025 to 2030, culminating in a forecasted valuation of US$2.74 billion by the end of the period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials; the rising demand for personalized medicine in oncology; and advancements in genetic engineering.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
